Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers.
作者信息
Hrdinová Johana, D'Angelo Silvia, Graça Nuno A G, Ercig Bogac, Vanhoorelbeke Karen, Veyradier Agnès, Voorberg Jan, Coppo Paul
机构信息
Department of Plasma Proteins, Sanquin-Academic Medical Center Landsteiner Laboratory, Amsterdam, the Netherlands
PharmaTarget B.V., Maastricht, the Netherlands
出版信息
Haematologica. 2021 Mar 1;106(3):924. doi: 10.3324/haematol.2020.278244.
Abstract
摘要
相似文献
1
Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers.剖析免疫性血栓性血小板减少性紫癜的病理生理学：基因与环境触发因素之间的相互作用
Haematologica. 2021 Mar 1;106(3):924. doi: 10.3324/haematol.2020.278244.
2
Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers.解析免疫性血栓性血小板减少性紫癜的病理生理学：基因与环境触发因素的相互作用。
Haematologica. 2018 Jul;103(7):1099-1109. doi: 10.3324/haematol.2016.151407. Epub 2018 Apr 19.
3
Immunotherapy for thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜的免疫疗法。
Curr Opin Hematol. 2005 Sep;12(5):359-63. doi: 10.1097/01.moh.0000170534.33517.99.
4
Post-Partum Thrombotic Thrombocytopenic Purpura (TTP) in a Patient with known Idiopathic (Immune) Thrombocytopenic Purpura: a case report and review of the literature.一名已知患有特发性（免疫性）血小板减少性紫癜的患者发生产后血栓性血小板减少性紫癜：病例报告及文献综述
J Med Case Rep. 2018 Jun 1;12(1):147. doi: 10.1186/s13256-018-1692-1.
5
Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy.伴有严重ADAMTS13缺乏的成人期血栓性微血管病（血栓性血小板减少性紫癜）的流行病学和病理生理学：法国全国血栓性微血管病登记处的横断面分析
Lancet Haematol. 2016 May;3(5):e237-45. doi: 10.1016/S2352-3026(16)30018-7. Epub 2016 Apr 16.
6
Current management of thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜的当前管理
Curr Opin Hematol. 2008 Sep;15(5):445-50. doi: 10.1097/MOH.0b013e328309ec62.
7
An update on the pathogenesis and management of acquired thrombotic thrombocytopenic purpura.获得性血栓性血小板减少性紫癜的发病机制与治疗进展
Curr Opin Neurol. 2003 Jun;16(3):367-73. doi: 10.1097/01.wco.0000073939.19076.78.
8
Inherited thrombotic thrombocytopenic purpura mimicking immune thrombocytopenic purpura during pregnancy: a case report.孕期表现为免疫性血小板减少性紫癜的遗传性血栓性血小板减少性紫癜：一例报告
J Med Case Rep. 2018 Jan 22;12(1):15. doi: 10.1186/s13256-017-1545-3.
9
Thrombotic thrombocytopenic purpura. I. Pathophysiology and clinical manifestations.
Am J Pediatr Hematol Oncol. 1984 Winter;6(4):425-30. doi: 10.1097/00043426-198424000-00007.
10
Thrombotic thrombocytopenic purpura or immune thrombocytopenia in a sickle cell/β+-thalassemia patient: a rare and challenging condition.镰状细胞/β+地中海贫血患者出现血栓性血小板减少性紫癜或免疫性血小板减少症：一种罕见且具有挑战性的病症。
Transfus Apher Sci. 2014 Oct;51(2):175-7. doi: 10.1016/j.transci.2014.09.001. Epub 2014 Sep 16.
引用本文的文献
1
The features and risk factors of thrombotic thrombocytopenic purpura in systemic lupus erythematosus.系统性红斑狼疮中血栓性血小板减少性紫癜的特征及危险因素
Orphanet J Rare Dis. 2025 Apr 28;20(1):203. doi: 10.1186/s13023-025-03741-0.
2
Mechanistic insight into multiple antibody binding to ADAMTS13 in immune thrombotic thrombocytopenic purpura.免疫性血栓性血小板减少性紫癜中多种抗体与ADAMTS13结合的机制研究
Res Pract Thromb Haemost. 2024 Oct 23;8(7):102603. doi: 10.1016/j.rpth.2024.102603. eCollection 2024 Oct.
3
A Long-Term Follow-Up Study in Immune-Mediated Thrombotic Thrombocytopenic Purpura: What Are the Outcomes?免疫介导性血栓性血小板减少性紫癜的长期随访研究：结果如何？
J Clin Med. 2023 Nov 25;12(23):7305. doi: 10.3390/jcm12237305.
4
Mechanisms of inhibition of human monoclonal antibodies in immune thrombotic thrombocytopenic purpura.人类单克隆抗体在免疫性血栓性血小板减少性紫癜中的抑制机制。
Blood. 2023 Jun 15;141(24):2993-3005. doi: 10.1182/blood.2022019252.
Zotero 插件